{
 "attribution": "出典：EDINET（金融庁）／図解経済が加工",
 "code": "177A",
 "name": "コージンバイオ",
 "listed": true,
 "edinet_code": "E38689",
 "name_en": "Kohjin Bio Co., Ltd.",
 "former_names": [],
 "sector": "医薬品",
 "sector_scheme": "東証33業種（EDINET コードリスト）",
 "fiscal_year_end": "3月末日",
 "accounting_standard": "日本基準",
 "consolidated": true,
 "units": {
  "revenue": "億円",
  "operating_income": "億円",
  "net_income": "億円",
  "avg_salary": "円",
  "employees": "人",
  "share_pct": "%"
 },
 "units_note": "売上・営業利益・純利益は億円未満を四捨五入した整数。区分の売上は小数第1位まで。",
 "labels": {
  "revenue": "売上高",
  "operating_income": "営業利益",
  "net_income": "親会社株主に帰属する当期純利益"
 },
 "latest": {
  "fiscal_period": "2026年3月期",
  "revenue": 49,
  "operating_income": 3,
  "net_income": 3,
  "avg_salary": 5535000,
  "employees": 176
 },
 "series": [
  {
   "fiscal_period": "2022年3月期",
   "revenue": 39,
   "operating_income": 9,
   "net_income": 6,
   "avg_salary": null,
   "employees": 130
  },
  {
   "fiscal_period": "2023年3月期",
   "revenue": 47,
   "operating_income": 13,
   "net_income": 8,
   "avg_salary": null,
   "employees": 139
  },
  {
   "fiscal_period": "2024年3月期",
   "revenue": 48,
   "operating_income": 6,
   "net_income": 4,
   "avg_salary": 5575000,
   "employees": 159
  },
  {
   "fiscal_period": "2025年3月期",
   "revenue": 52,
   "operating_income": 10,
   "net_income": 8,
   "avg_salary": 5623000,
   "employees": 167
  },
  {
   "fiscal_period": "2026年3月期",
   "revenue": 49,
   "operating_income": 3,
   "net_income": 3,
   "avg_salary": 5535000,
   "employees": 176
  }
 ],
 "series_order": "古い順（最大5期）",
 "avg_salary_scope": "提出会社（単体）",
 "employees_scope": "連結",
 "segments": {
  "fiscal_period": "2026年3月期",
  "basis": "revenue",
  "unit": "億円",
  "items": [
   {
    "name": "組織培養事業",
    "value": 25.4,
    "share_pct": 51.4
   },
   {
    "name": "微生物事業",
    "value": 14.2,
    "share_pct": 28.8
   },
   {
    "name": "細胞加工事業",
    "value": 9.7,
    "share_pct": 19.7
   }
  ]
 },
 "sources": {
  "edinet_code": "E38689",
  "document_ids": [
   "S100YB5D",
   "S100W2HI",
   "S100TX40"
  ],
  "documents": [
   {
    "doc_id": "S100YB5D",
    "period_end": "2026-03-31",
    "submitted": "2026-06-23 15:04",
    "url": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YB5D"
   },
   {
    "doc_id": "S100W2HI",
    "period_end": "2025-03-31",
    "submitted": "2025-06-24 16:06",
    "url": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100W2HI"
   },
   {
    "doc_id": "S100TX40",
    "period_end": "2024-03-31",
    "submitted": "2024-06-28 15:00",
    "url": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100TX40"
   }
  ]
 },
 "page_url": "https://zukaikeizai.com/kaisha/177A/",
 "kessan_url": "https://zukaikeizai.com/kaisha/177A/kessan/",
 "data_url": "https://zukaikeizai.com/api/kaisha/177A.json",
 "license": {
  "license": "CC BY 4.0",
  "license_url": "https://creativecommons.org/licenses/by/4.0/deed.ja",
  "attribution": "出典：EDINET（金融庁）／図解経済が加工",
  "credit": "図解経済 https://zukaikeizai.com/",
  "source": "EDINET（金融庁）の有価証券報告書",
  "source_terms": "公共データ利用規約（第1.0版）",
  "source_terms_url": "https://www.digital.go.jp/resources/open_data/public_data_license_v1.0",
  "notice": "図解経済が加工したものです。金融庁が内容を保証するものではありません。投資の助言ではありません。",
  "contact": "contact@zukaikeizai.com"
 }
}